{"id":16173,"date":"2025-05-07T10:59:14","date_gmt":"2025-05-07T10:59:14","guid":{"rendered":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-ritning\/"},"modified":"2025-05-07T12:24:36","modified_gmt":"2025-05-07T12:24:36","slug":"ederagenhelse-no-ritning","status":"publish","type":"page","link":"https:\/\/ederagenhelse.no\/ny2026\/sv\/ederagenhelse-no-ritning\/","title":{"rendered":"ederagenhelse.no\/ritning"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"16173\" class=\"elementor elementor-16173 elementor-16056\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c094edd e-flex e-con-boxed e-con e-parent\" data-id=\"c094edd\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cce4d43 elementor-widget elementor-widget-heading\" data-id=\"cce4d43\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">INBJUDAN TILL TECKNING AV AKTIER I EDERAGEN AS<\/h1>\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-47f6a23 e-con-full e-flex e-con e-child\" data-id=\"47f6a23\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3f23b62 elementor-widget elementor-widget-text-editor\" data-id=\"3f23b62\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Prenumeration ska ske p\u00e5 fastst\u00e4llt digitalt formul\u00e4r och i enlighet med det f\u00f6rfarande som finns tillg\u00e4ngligt p\u00e5 <a href=\"https:\/\/ederagenhelse.no\/ny2026\/sv\/\" target=\"_blank\" rel=\"noopener\">www.ederagenhelse.no.<\/a> Blanketten kan skickas elektroniskt, skrivas ut f\u00f6r underskrift och skickas till <a href=\"mailto:tegning@ederagen.no\">tegning@ederagen.no,<\/a> eller per post till <\/p><p><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\"><strong>EderaGen AS<\/strong><br><\/span><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">Litle\u00e5svegen 13<br><\/span><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">5132 Nyborg, Sverige<\/span><\/p><p><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">Sista dag f\u00f6r prenumeration:  <\/span><strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">1 juni 2025 vid 23:59<\/strong><\/p><p><strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">Bilagor f\u00f6r nedladdning:  <\/strong><\/p><ul><li><a href=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2025\/05\/EderaGen-emisjon-var-2025-FINAL-med-forside-1.pdf\">INBJUDAN TILL TECKNING AV AKTIER I EDERAGEN AS (PDF)<\/a><\/li><li><a href=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2025\/05\/2025.05.06-Tegningsdokument-for-tegning-av-aksjer-FINAL.docx\" target=\"_blank\" rel=\"noopener\">Teckningsdokument f\u00f6r teckning av aktier i EderaGen AS<\/a><\/li><li><a href=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2025\/05\/VEDTEKTER-for-EderaGen-2025.04.24.pdf\" target=\"_blank\" rel=\"noopener\">Bolagsordning (PDF)<\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cc4da33 elementor-hidden-widescreen elementor-hidden-desktop elementor-hidden-laptop elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-text-editor\" data-id=\"cc4da33\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Beslut om kapital\u00f6kning fattat av bolagsst\u00e4mman den 24 april 2025 <\/h3><p> <\/p><h4>Beslut om aktiekurs och antal aktier i samband med nyemission.<\/h4><p> <\/p><p>F\u00f6r mellanfinansiering av bolagets verksamhet beslutades att aktiekapitalet kan \u00f6kas genom teckning av upp till 1.250.000 nya aktier, var och en med ett nominellt v\u00e4rde av 1.250.000 NOK. 1,-. En betalning p\u00e5 NOK. 8,- f\u00f6r varje aktie, totalt upp till NOK.  10.000.000. De nya aktierna kan tecknas av vem som helst, med f\u00f6rbeh\u00e5ll f\u00f6r bolagsordningens begr\u00e4nsning att f\u00f6rv\u00e4rv av aktier i bolaget endast f\u00e5r ske efter styrelsens godk\u00e4nnande. Varje teckning m\u00e5ste avse minst 2.000 aktier. <\/p><p> <\/p><p>Sista dag f\u00f6r teckning av aktier \u00e4r den 1 juni 2025. Sista dag f\u00f6r betalning av aktierna ska vara den 10 juni 2025. Aktierna ger r\u00e4tt till utdelning omedelbart. Kostnader i samband med teckningen ska t\u00e4ckas av bolaget. Dessa kostnader antas inte \u00f6verstiga NOK.       10.000.<\/p><p> <\/p><h4>\u00d6vrig information<\/h4><p> <\/p><ol><li>a. Bolagets nuvarande bolagsordning, som antogs av bolagsst\u00e4mman den 24 april 2025, finns tillg\u00e4nglig via denna l\u00e4nk.  <\/li><li>b. Det nuvarande aktiekapitalet \u00e4r NOK. 2.548.100 f\u00f6rdelat p\u00e5 2.548.100 aktier med ett nominellt v\u00e4rde om 1 NOK.  <\/li><li>c. Aktiekursen f\u00f6r nya teckningar p\u00e5 NOK. 8,00 per aktie motsvarar genomsnittskursen f\u00f6r tidigare emissioner till nuvarande \u00e4gare.  <\/li><li>d. Vid \u00f6verl\u00e5telse av aktier skall aktie\u00e4garna inte ha f\u00f6retr\u00e4desr\u00e4tt. Detta g\u00e4ller s\u00e5v\u00e4l aktier som byter \u00e4gare som nyteckning av aktier, jfr \u00a7 6 i bolagsordningen.  <\/li><li>e. Extra bolagsst\u00e4mma i bolaget ska h\u00e5llas s\u00e5 snart det totala antalet nytecknade aktier \u00e4r k\u00e4nt, varvid \u00a7 4 i bolagets bolagsordning ska \u00e4ndras i enlighet med det nya aktiekapitalet och antalet aktier. <\/li><li>f. Senast fastst\u00e4llda \u00e5rsredovisning finns tillg\u00e4nglig p\u00e5 bolagets kontor. <\/li><li>g. Observera att det alltid finns en risk f\u00f6rknippad med aktiek\u00f6p. <\/li><li> <\/li><\/ol><h4>Reglering av aktie\u00e4gartillskott<\/h4><p> <\/p><p>Aktiedep\u00e5erna ska betalas senast den 10 juni 2025 kl. 23:59 till EderaGen AS:s konto nr 1506.01.03612 i Den Norske Bank.  <\/p><p> <\/p><p> <\/p><p>Anm\u00e4lningssedeln skickas in genom att trycka p\u00e5 knappen SEND nedan. Genom att g\u00f6ra detta bekr\u00e4ftar aktietecknaren att villkoren f\u00f6r aktieteckningen har accepterats och att teckningen \u00e4r bindande. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9924e55 e-flex e-con-boxed e-con e-parent\" data-id=\"9924e55\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-7cd8dbd e-con-full e-flex e-con e-child\" data-id=\"7cd8dbd\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c13b216 elementor-widget elementor-widget-text-editor\" data-id=\"c13b216\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>&#8221;Om m\u00e4nniskan forts\u00e4tter att ber\u00f6va immunsystemet den<br>p\u00e5verkan som det har anpassats till genom evolutionen,<br>kommer det att bli n\u00f6dv\u00e4ndigt att hitta s\u00e4tt att ers\u00e4tta det p\u00e5 konstgjord v\u00e4g&#8221;.<br>Immunology Today, 19(3), 114-116, 1998.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-86cc2fe e-flex e-con-boxed e-con e-parent\" data-id=\"86cc2fe\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8ba4b98 elementor-widget elementor-widget-heading\" data-id=\"8ba4b98\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">1. Teckning av aktier<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-381cb06 elementor-widget elementor-widget-text-editor\" data-id=\"381cb06\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Fram till och med den 1 juni 2025 kan aktier i EderaGen AS tecknas f\u00f6r upp till 10 miljoner NOK till en kurs om 8 NOK per aktie. Aktiekursen motsvarar genomsnittskursen f\u00f6r tidigare emissioner till nuvarande \u00e4gare. Minsta volym \u00e4r satt till 2 000 aktier. Den som \u00e4r intresserad av att delta i emissionen m\u00e5ste anm\u00e4la sig p\u00e5 anm\u00e4lningssedeln, som du hittar genom att f\u00f6lja <a href=\"#skjema\">denna l\u00e4nk.<\/a>     <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f4cf928 elementor-widget elementor-widget-heading\" data-id=\"f4cf928\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">2. Utnyttjande av emissionsbeloppet<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bbbe78e elementor-widget elementor-widget-text-editor\" data-id=\"bbbe78e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Genom emissionen s\u00e4kerst\u00e4lls att bolaget omedelbart kan genomf\u00f6ra sin plan f\u00f6r \u00f6kad marknadsf\u00f6ring. Den ger ocks\u00e5 en st\u00f6rre finansiell handlingsfrihet s\u00e5 att bolaget kan g\u00e5 vidare med nya aktiviteter baserade p\u00e5 den egna patenterade uppfinningen. Sammantaget kommer detta att ligga till grund f\u00f6r en nyemission inom tv\u00e5 \u00e5r &#8211; till en h\u00f6gre aktiekurs \u00e4n idag.  <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8f1e418 elementor-widget elementor-widget-heading\" data-id=\"8f1e418\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">3. Status f\u00f6r<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0c7c5c7 elementor-widget elementor-widget-text-editor\" data-id=\"0c7c5c7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Professor emeritus Jan Raa \u00e4r den st\u00f6rsta aktie\u00e4garen i EderaGen AS. Tillsammans med ledningen f\u00f6r EderaGen AS har han lett den vetenskapliga, tekniska och kommersiella utvecklingen av bolagets produkter. <br><br><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">EderaGard och EcoGard s\u00e4ljs i n\u00e4tbutiken av EderaGen Helse AS (EderaGen AS \u00e4ger 100% av f\u00f6rs\u00e4ljningsbolaget EderaGen Helse AS). Produkterna har blivit k\u00e4nda p\u00e5 marknaden genom podcasts, digital marknadsf\u00f6ring och medierapportering. Idag har bolaget cirka 4.000 kunder och anv\u00e4ndarna av produkterna har gett mycket positiv feedback. Produktf\u00f6rs\u00e4ljningen har \u00f6kat s\u00e5 pass mycket att bolaget sedan f\u00f6rra sommaren har ett nollresultat. Den st\u00f6rsta risken i samband med utveckling och kommersialisering har d\u00e4rf\u00f6r redan tagits av de nuvarande \u00e4garna.      <\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-824cb40 elementor-widget elementor-widget-heading\" data-id=\"824cb40\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">4. Produkternas beteende<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-99013c2 elementor-widget elementor-widget-text-editor\" data-id=\"99013c2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Bolagets norska patent nr 346800 har titeln &#8221;Deconstructed soil composition&#8221;. Patentet avser en jordkomposition som stimulerar tillv\u00e4xten av tarmbakterier som f\u00f6rsvinner hos personer med livsstilssjukdomar och samtidigt h\u00e4mmar bakterier som blir mer dominerande och bidrar till dessa sjukdomar. Detta verkningss\u00e4tt \u00e4r unikt, bland annat eftersom den patenterade sammans\u00e4ttningen varken stimulerar eller h\u00e4mmar tarmbakterier som lever var f\u00f6r sig. Ist\u00e4llet verkar den genom att f\u00f6rskjuta den ekologiska balansen i tarmmikrobiomet i en gynnsam riktning. Det \u00e4r d\u00e4rf\u00f6r inte ett anti-biotikum, inte ett pro-biotikum eller ett pre-biotikum, utan ett helt nytt koncept: Ekosystemisk. Det finns inga andra produkter p\u00e5 marknaden med ett liknande verkningss\u00e4tt.     <\/p><p><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">EderaGard \u00e4r den f\u00f6rsta produkten som h\u00e4rr\u00f6r fr\u00e5n detta patent. EcoGard minskar inflammation och st\u00e4rker det naturliga immunf\u00f6rsvaret i tarmslemhinnan, vilket bidrar till att f\u00f6rhindra mikrobiella obalanser (dysbios) som predisponerar f\u00f6r sjukdom. <\/span><\/p><p><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">F\u00f6r en mer detaljerad beskrivning av produkterna och hur de fungerar, se <a href=\"https:\/\/ederagenhelse.no\/ny2026\/\">www.ederagenhelse.no<\/a> och <a href=\"http:\/\/www.ederagen.no\/\">www.ederagen.no.<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0a5cb22 elementor-widget elementor-widget-heading\" data-id=\"0a5cb22\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">5. Behovet av naturlig immunologisk stimulering<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-123ddd0 elementor-widget elementor-widget-text-editor\" data-id=\"123ddd0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>EderaGard och EcoGard inneh\u00e5ller osm\u00e4ltbara naturliga \u00e4mnen (humin och beta-1,3\/1,6-glukan) som finns i gammal skogsmark, men som har renats och steriliserats. Det \u00e4r \u00e4mnen som medvetet tas bort fr\u00e5n moderna livsmilj\u00f6er i v\u00e4sterl\u00e4ndska samh\u00e4llen, men som det m\u00e4nskliga immunsystemet har anpassats till genom evolutionen. Brist p\u00e5 naturlig stimulans i dagens sanerade milj\u00f6 leder till immunologiska &#8221;missf\u00f6rst\u00e5nd&#8221; som allergier och astma, och till den typ av ekologisk nedbrytning (dysbios) i tarmfloran som f\u00f6rekommer hos personer med diabetes, fetma, Parkinsons, autism och alla andra livsstilssjukdomar.  <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-85e0b2f elementor-widget elementor-widget-heading\" data-id=\"85e0b2f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">6. Ut\u00f6kad marknadsf\u00f6ring<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-99ea1e2 elementor-widget elementor-widget-text-editor\" data-id=\"99ea1e2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Bolagets produkter har f\u00e5tt mycket positiv publicitet bland m\u00e4nniskor som \u00e4r medvetna<br>om sambandet mellan dagens livsstilssjukdomar och mikrobiell dysbios i tarmen. En utvidgad marknadsplan syftar till att skapa medvetenhet \u00e4ven hos m\u00e4nniskor som inte k\u00e4nner till dessa samband. Det inneb\u00e4r masskommunikation riktad till bredare befolkningssegment. M\u00e5let \u00e4r att m\u00e5ngdubbla f\u00f6rs\u00e4ljningen och d\u00e4rmed v\u00e4sentligt st\u00e4rka bolagets finansiella grund. Planen omfattar bland annat ut\u00f6kad digital marknadsf\u00f6ring med annonsering i sociala medier och n\u00e4ttidningar, anv\u00e4ndning av influencers och dedikerade marknadskoordinatorer samt involvering av yrkesgrupper med kunskap om produkterna.    <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b72e675 elementor-widget elementor-widget-heading\" data-id=\"b72e675\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">7. Nya projekt<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5b99c0e elementor-widget elementor-widget-text-editor\" data-id=\"5b99c0e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>V\u00e4rdet av bolagets norska patent nr 346800 \u00e4r sv\u00e5rt att kvantifiera, och EderaGen AS har internationella patentans\u00f6kningar under behandling i Europa, Japan, Kanada, USA, Mexiko och Brasilien.<br>\u00c4gandet av en unik och skyddad teknologi \u00f6ppnar upp f\u00f6r m\u00e5nga m\u00f6jliga produktformuleringar med betydande h\u00e4lsopotential.<br><br><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">EderaGen AS har hittills inte haft de resurser som kr\u00e4vs f\u00f6r att driva s\u00e5dana nya ans\u00f6kningar &#8211; det finns flera. Som ett f\u00f6rsta steg avser bolaget nu att unders\u00f6ka om produkter baserade p\u00e5 patentet \u00f6kar den terapeutiska effekten av immunterapi. Resonemanget bygger p\u00e5 litteraturstudier som har dokumenterat att effekten av cancerantikroppar kan bli kraftigt reducerad &#8211; eller obefintlig &#8211; n\u00e4r vissa tarmbakterier \u00e4r i minoritet och andra blir dominerande. Detta \u00e4r h\u00f6gst relevant f\u00f6r EderaGen AS eftersom det \u00e4r ett faktum att bolagets ekosystemics gynnar samma bakteriearter som ger en b\u00e4ttre terapeutisk effekt av cancerantikroppar, och undertrycker de arter som har motsatt effekt.   <\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9cc57ee elementor-widget elementor-widget-heading\" data-id=\"9cc57ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">8. Vill du vara med och vidareutveckla EderaGen AS?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6d59935 elementor-widget elementor-widget-text-editor\" data-id=\"6d59935\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Genom emissionen \u00f6kar m\u00f6jligheten f\u00f6r EderaGen AS att realisera sin potential. De som vill komma &#8221;tidigt ombord&#8221; kan teckna sig p\u00e5 formul\u00e4ret som finns h\u00e4r. <\/p><p><strong>Bergen 6 maj 2025 <\/strong><br><strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">Ask<\/span><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bde70a9 e-flex e-con-boxed e-con e-parent\" data-id=\"bde70a9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c076ede elementor-widget elementor-widget-heading\" data-id=\"c076ede\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Det ifyllda formul\u00e4ret m\u00e5ste \u00e5ters\u00e4ndas senast den 1 juni 2025.  23:59<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-895b747 elementor-widget elementor-widget-wpforms\" data-id=\"895b747\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"skjema\" data-widget_type=\"wpforms.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style id=\"wpforms-css-vars-elementor-widget-895b747\">\n\t\t\t\t.elementor-widget-wpforms.elementor-element-895b747 {\n\t\t\t\t--wpforms-field-border-radius: 30px;\n--wpforms-field-border-color: #4A362E73;\n--wpforms-field-border-color-spare: #4A362E73;\n--wpforms-button-border-radius: 50px;\n--wpforms-button-background-color: #F4E7D2;\n--wpforms-label-color: #F4E7D2;\n--wpforms-label-sublabel-color: #271918;\n\t\t\t}\n\t\t\t<\/style><div class=\"wpforms-container wpforms-container-full wpforms-render-modern\" id=\"wpforms-16126\"><form id=\"wpforms-form-16126\" class=\"wpforms-validate wpforms-form wpforms-ajax-form\" data-formid=\"16126\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/ny2026\/sv\/wp-json\/wp\/v2\/pages\/16173\" data-token=\"b53093cf48805842cddb6249ee4df148\" data-token-time=\"1777220878\"><noscript class=\"wpforms-error-noscript\">Aktivera JavaScript i din webbl\u00e4sare f\u00f6r att fylla i formul\u00e4ret.<\/noscript><div id=\"wpforms-error-noscript\" style=\"display: none;\">Aktivera JavaScript i din webbl\u00e4sare f\u00f6r att fylla i formul\u00e4ret.<\/div><div class=\"wpforms-field-container\"><div id=\"wpforms-16126-field_2-container\" class=\"wpforms-field wpforms-field-layout\" data-field-id=\"2\"><div class=\"wpforms-field-layout-rows wpforms-field-large\"><div class=\"wpforms-layout-row\"><div class=\"wpforms-layout-column wpforms-layout-column-25\"><div id=\"wpforms-16126-field_11-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"11\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_11\">Navn \/ firma <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_11\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][11]\" aria-errormessage=\"wpforms-16126-field_11-error\" required><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-25\"><div id=\"wpforms-16126-field_4-container\" class=\"wpforms-field wpforms-field-number\" data-field-id=\"4\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_4\">Antal aktier <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"number\" id=\"wpforms-16126-field_4\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][4]\" value=\"2000\" min=\"2000\" step=\"any\" aria-errormessage=\"wpforms-16126-field_4-error\" aria-describedby=\"wpforms-16126-field_4-description\" required><div id=\"wpforms-16126-field_4-description\" class=\"wpforms-field-description\">Kr. 8,- per aksje<\/div><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_24-container\" class=\"wpforms-field wpforms-field-text wpf-disable-field\" data-field-id=\"24\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_24\">Bel\u00f8p \u00e5 betale (kroner)<\/label><input type=\"text\" id=\"wpforms-16126-field_24\" class=\"wpforms-field-medium\" name=\"wpforms[fields][24]\" aria-errormessage=\"wpforms-16126-field_24-error\" ><\/div><\/div><\/div><\/div><\/div><div id=\"wpforms-16126-field_9-container\" class=\"wpforms-field wpforms-field-html\" data-field-id=\"9\"><div id=\"wpforms-16126-field_9\" aria-errormessage=\"wpforms-16126-field_9-error\"><p><b>Minsta antal aktier per aktieteckning \u00e4r 2 000 aktier \u00e0 NOK. 8,-.<\/b><\/p><\/div><\/div><div id=\"wpforms-16126-field_8-container\" class=\"wpforms-field wpforms-field-html\" data-field-id=\"8\"><div id=\"wpforms-16126-field_8\" aria-errormessage=\"wpforms-16126-field_8-error\"><h5>Ytterligare information om abonnenten<\/h5><\/div><\/div><div id=\"wpforms-16126-field_10-container\" class=\"wpforms-field wpforms-field-layout\" data-field-id=\"10\"><div class=\"wpforms-field-layout-rows wpforms-field-large\"><div class=\"wpforms-layout-row\"><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_12-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"12\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_12\">Fullt navn \/ firmanavn <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_12\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][12]\" aria-errormessage=\"wpforms-16126-field_12-error\" required><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_13-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"13\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_13\">F\u00f8dselsnummer (11 sifre) eller organisasjonsnummer (firma) <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_13\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][13]\" aria-errormessage=\"wpforms-16126-field_13-error\" required><\/div><\/div><\/div><div class=\"wpforms-layout-row\"><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_15-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"15\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_15\">Gateadresse \/ boligadresse <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_15\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][15]\" aria-errormessage=\"wpforms-16126-field_15-error\" required><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_16-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"16\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_16\">Postnummer og poststed <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_16\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][16]\" aria-errormessage=\"wpforms-16126-field_16-error\" required><\/div><\/div><\/div><div class=\"wpforms-layout-row\"><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_18-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"18\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_18\">Skattekommune <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_18\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][18]\" aria-errormessage=\"wpforms-16126-field_18-error\" required><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_31-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"31\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_31\">E-post <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_31\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][31]\" aria-errormessage=\"wpforms-16126-field_31-error\" required><\/div><\/div><\/div><div class=\"wpforms-layout-row\"><div class=\"wpforms-layout-column wpforms-layout-column-50\"><div id=\"wpforms-16126-field_32-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"32\"><label class=\"wpforms-field-label\" for=\"wpforms-16126-field_32\">Mobiltelefon <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-16126-field_32\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][32]\" aria-errormessage=\"wpforms-16126-field_32-error\" required><\/div><\/div><div class=\"wpforms-layout-column wpforms-layout-column-50\"><\/div><\/div><\/div><\/div><div id=\"wpforms-16126-field_28-container\" class=\"wpforms-field wpforms-field-html\" data-field-id=\"28\"><div id=\"wpforms-16126-field_28\" aria-errormessage=\"wpforms-16126-field_28-error\"><span style=\"font-size:22px;font-weight:bold;\">Beslutning om kapitalforh\u00f8yelse vedtatt i generalforsamling, den 24. april 2025<\/span>\r\n<br \/><br \/>\r\n\r\n<span style=\"font-size:18px;font-weight:bold;\">Beslutning om aksjekurs og antall aksjer ved nytegning i emisjon.<\/span>\r\n&nbsp;<br \/><br \/>\r\n\r\nTil mellomfinansiering av selskapets aktiviteter ble det besluttet at aksjekapitalen kan \u00f8kes ved nytegning av inntil 1.250.000 aksjer, hver p\u00e5lydende kr. 1,-. Det skal betales kr. 8,- for hver aksje, totalt inntil kr. 10.000.000. Enhver kan tegne de nye aksjene, med den vedtektsfestede begrensning at kj\u00f8p av aksjer i selskapet er betinget av styrets samtykke. Hver tegning skal v\u00e6re p\u00e5 minst 2.000 aksjer.\r\n\r\n&nbsp;<br \/><br \/>\r\n\r\nFristen for tegning av aksjer er 1. juni 2025. Frist for oppgj\u00f8r av aksjene skal v\u00e6re 10. juni 2025. Aksjene gir rett til utbytte umiddelbart. Utgifter forbundet med tegningen skal dekkes av selskapet. Disse utgiftene antas \u00e5 ikke overstige kr. 10.000.\r\n\r\n&nbsp;<br \/><br \/>\r\n<span style=\"font-size:18px;font-weight:bold;\">Andre opplysninger<\/span>\r\n&nbsp;\r\n<br \/>\r\na. Selskapets gjeldende vedtekter som vedtatt i generalforsamling 24. april 2025, finnes i <a href=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2025\/05\/VEDTEKTER-for-EderaGen-2025.04.24.pdf\" target=\"_blank\" rel=\"noopener\">denne linken.<\/a>\r\n\r\n\r\n<br \/>\r\nb. N\u00e5v\u00e6rende aksjekapital er p\u00e5 kr. 2.548.100 fordelt p\u00e5 2.548.100 aksjer p\u00e5lydende kr.1,-.\r\n<br \/>\r\nc. Aksjeprisen ved nytegning p\u00e5 kr. 8,- per aksje svarer til gjennomsnittsprisen for tidligere emisjoner mot dagens eiere.\r\n<br \/>\r\nd. Ved overgang av aksjer skal aksjeeierne ikke ha forkj\u00f8psrett. Dette gjelder b\u00e5de aksjer som skifter eier og nytegning av aksjer, ref. vedtektenes \u00a76.\r\n<br \/>\r\ne. Det avholdes ekstraordin\u00e6r generalforsamling i selskapet s\u00e5 snart det totale antallet nytegnede aksjer er kjent, hvorp\u00e5 \u00a74 i selskapets vedtekter endres i samsvar med ny aksjekapital og antall aksjer.\r\n<br \/>\r\nf. Siste godkjente \u00e5rsregnskap er lagt ut p\u00e5 selskapets kontor.\r\n<br \/>\r\ng. Vi gj\u00f8r oppmerksom p\u00e5 at det alltid er risiko knyttet til aksjekj\u00f8p.\r\n<br \/><br \/>\r\n\r\n<span style=\"font-size:18px;font-weight:bold;\">Oppgj\u00f8r for aksjeinnskuddene<\/span>\r\n<br \/>\r\n\r\nAksjeinnskuddene skal gj\u00f8res opp innen den 10. juni 2025 kl. 23:59 til EderaGen AS sin konto nr. 1506.01.03612 i Den Norske Bank.\r\n\r\n<\/div><\/div>\t\t<div id=\"wpforms-16126-field_1-container\"\n\t\t\tclass=\"wpforms-field wpforms-field-text\"\n\t\t\tdata-field-type=\"text\"\n\t\t\tdata-field-id=\"1\"\n\t\t\t>\n\t\t\t<label class=\"wpforms-field-label\" for=\"wpforms-16126-field_1\" >Skattekommune (kroner) (firma)<\/label>\n\t\t\t<input type=\"text\" id=\"wpforms-16126-field_1\" class=\"wpforms-field-medium\" name=\"wpforms[fields][1]\" >\n\t\t<\/div>\n\t\t<div id=\"wpforms-16126-field_30-container\" class=\"wpforms-field wpforms-field-checkbox\" data-field-id=\"30\"><fieldset><legend class=\"wpforms-field-label\"> <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/legend><ul id=\"wpforms-16126-field_30\" class=\"wpforms-field-required\"><li class=\"choice-1 depth-1\"><input type=\"checkbox\" id=\"wpforms-16126-field_30_1\" name=\"wpforms[fields][30][]\" value=\"Tegningsskjemaet sendes inn ved \u00e5 trykke p\u00e5 knappen merket SEND nedenfor. Med dette bekrefter aksjetegner at betingelsene for aksjetegningen er akseptert, og at tegningen er forpliktende.\" aria-errormessage=\"wpforms-16126-field_30_1-error\" required ><label class=\"wpforms-field-label-inline\" for=\"wpforms-16126-field_30_1\">Tegningsskjemaet sendes inn ved \u00e5 trykke p\u00e5 knappen merket SEND nedenfor. Med dette bekrefter aksjetegner at betingelsene for aksjetegningen er akseptert, og at tegningen er forpliktende.<\/label><\/li><\/ul><\/fieldset><\/div><div id=\"wpforms-16126-field_19-container\" class=\"wpforms-field wpforms-field-layout\" data-field-id=\"19\"><\/div><script>\n\t\t\t\t( function() {\n\t\t\t\t\tconst style = document.createElement( 'style' );\n\t\t\t\t\tstyle.appendChild( document.createTextNode( '#wpforms-16126-field_1-container { position: absolute !important; overflow: hidden !important; display: inline !important; height: 1px !important; width: 1px !important; z-index: -1000 !important; padding: 0 !important; } #wpforms-16126-field_1-container input { visibility: hidden; } #wpforms-conversational-form-page #wpforms-16126-field_1-container label { counter-increment: none; }' ) );\n\t\t\t\t\tdocument.head.appendChild( style );\n\t\t\t\t\tdocument.currentScript?.remove();\n\t\t\t\t} )();\n\t\t\t<\/script><\/div><!-- .wpforms-field-container --><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"16126\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/pages\/16173\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-16126\" class=\"wpforms-submit\" data-alt-text=\"Skickar...\" data-submit-text=\"Skicka in\" aria-live=\"assertive\" value=\"wpforms-submit\">Skicka in<\/button><img decoding=\"async\" src=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" class=\"wpforms-submit-spinner\" style=\"display: none;\" width=\"26\" height=\"26\" alt=\"Laddar\"><\/div><\/form><\/div>  <!-- .wpforms-container -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>INBJUDAN TILL TECKNING AV AKTIER I EDERAGEN AS Prenumeration ska ske p\u00e5 fastst\u00e4llt digitalt formul\u00e4r och i enlighet med det f\u00f6rfarande som finns tillg\u00e4ngligt p\u00e5 www.ederagenhelse.no. Blanketten kan skickas elektroniskt, skrivas ut f\u00f6r underskrift och skickas till tegning@ederagen.no, eller per post till EderaGen ASLitle\u00e5svegen 135132 Nyborg, Sverige Sista dag f\u00f6r prenumeration: 1 juni 2025 vid [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-16173","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ederagenhelse.no\/ritning - Ederagen Helse<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ederagenhelse.no\/ritning - Ederagen Helse\" \/>\n<meta property=\"og:description\" content=\"INBJUDAN TILL TECKNING AV AKTIER I EDERAGEN AS Prenumeration ska ske p\u00e5 fastst\u00e4llt digitalt formul\u00e4r och i enlighet med det f\u00f6rfarande som finns tillg\u00e4ngligt p\u00e5 www.ederagenhelse.no. Blanketten kan skickas elektroniskt, skrivas ut f\u00f6r underskrift och skickas till tegning@ederagen.no, eller per post till EderaGen ASLitle\u00e5svegen 135132 Nyborg, Sverige Sista dag f\u00f6r prenumeration: 1 juni 2025 vid [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/\" \/>\n<meta property=\"og:site_name\" content=\"Ederagen Helse\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-07T12:24:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/\",\"url\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/\",\"name\":\"ederagenhelse.no\\\/ritning - Ederagen Helse\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/wp-content\\\/plugins\\\/wpforms\\\/assets\\\/images\\\/submit-spin.svg\",\"datePublished\":\"2025-05-07T10:59:14+00:00\",\"dateModified\":\"2025-05-07T12:24:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/wp-content\\\/plugins\\\/wpforms\\\/assets\\\/images\\\/submit-spin.svg\",\"contentUrl\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/wp-content\\\/plugins\\\/wpforms\\\/assets\\\/images\\\/submit-spin.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/ederagenhelse-no-tegning\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ederagenhelse.no\\\/ritning\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#website\",\"url\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/\",\"name\":\"Ederagen Helse\",\"description\":\"Lidenskapelig opptatt av god helse og godt immunforsvar\",\"publisher\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#organization\",\"name\":\"Ederagen Helse\",\"url\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo-hvit-1.png\",\"contentUrl\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo-hvit-1.png\",\"width\":2560,\"height\":418,\"caption\":\"Ederagen Helse \"},\"image\":{\"@id\":\"https:\\\/\\\/ederagenhelse.no\\\/ny2026\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ederagenhelse.no\/ritning - Ederagen Helse","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sv_SE","og_type":"article","og_title":"ederagenhelse.no\/ritning - Ederagen Helse","og_description":"INBJUDAN TILL TECKNING AV AKTIER I EDERAGEN AS Prenumeration ska ske p\u00e5 fastst\u00e4llt digitalt formul\u00e4r och i enlighet med det f\u00f6rfarande som finns tillg\u00e4ngligt p\u00e5 www.ederagenhelse.no. Blanketten kan skickas elektroniskt, skrivas ut f\u00f6r underskrift och skickas till tegning@ederagen.no, eller per post till EderaGen ASLitle\u00e5svegen 135132 Nyborg, Sverige Sista dag f\u00f6r prenumeration: 1 juni 2025 vid [&hellip;]","og_url":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/","og_site_name":"Ederagen Helse","article_modified_time":"2025-05-07T12:24:36+00:00","og_image":[{"url":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"8 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/","url":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/","name":"ederagenhelse.no\/ritning - Ederagen Helse","isPartOf":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/#primaryimage"},"image":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/#primaryimage"},"thumbnailUrl":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg","datePublished":"2025-05-07T10:59:14+00:00","dateModified":"2025-05-07T12:24:36+00:00","breadcrumb":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/#primaryimage","url":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg","contentUrl":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/ederagenhelse.no\/ny2026\/ederagenhelse-no-tegning\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/ederagenhelse.no\/ny2026\/sv\/"},{"@type":"ListItem","position":2,"name":"ederagenhelse.no\/ritning"}]},{"@type":"WebSite","@id":"https:\/\/ederagenhelse.no\/ny2026\/#website","url":"https:\/\/ederagenhelse.no\/ny2026\/","name":"Ederagen Helse","description":"Lidenskapelig opptatt av god helse og godt immunforsvar","publisher":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ederagenhelse.no\/ny2026\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/ederagenhelse.no\/ny2026\/#organization","name":"Ederagen Helse","url":"https:\/\/ederagenhelse.no\/ny2026\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/ederagenhelse.no\/ny2026\/#\/schema\/logo\/image\/","url":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2024\/02\/logo-hvit-1.png","contentUrl":"https:\/\/ederagenhelse.no\/ny2026\/wp-content\/uploads\/2024\/02\/logo-hvit-1.png","width":2560,"height":418,"caption":"Ederagen Helse "},"image":{"@id":"https:\/\/ederagenhelse.no\/ny2026\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/pages\/16173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/comments?post=16173"}],"version-history":[{"count":6,"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/pages\/16173\/revisions"}],"predecessor-version":[{"id":16198,"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/pages\/16173\/revisions\/16198"}],"wp:attachment":[{"href":"https:\/\/ederagenhelse.no\/ny2026\/sv\/wp-json\/wp\/v2\/media?parent=16173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}